Abstract
Serum from humans with an upper respiratory viral infection (HSURVI) and from rabbits with a turpentine-induced acute inflammatory reaction (RSTIAR) reduces the activity of hepatic cytochrome P450 (P450) following 4 h of incubation. The aim of the present study was to assess the effect of HSURVIand RSTIAR on P450 activity and expression following 24 h of incubation with hepatocytes from control (HCONT) and rabbits with a TIAR (HINFLA). RSTIAR incubated with HCONT for 24 h reduced P450 content and activity, and CYP3A6 by 45%, without changing CYP1A1 and 1A2; when incubated with HINFLA, RSTIAR decreased P450 content and activity without affecting CYP1A1 or 1A2. HSURVI incubated for 4 h with HCONT decreased P450 activity without affecting the amounts of CYP1A1, 1A2, or 3A6, although when incubated for 24 h, P450 activity and CYP3A6 amount decreased. HSURVI incubated with HINFLA for 4 h reduced P450 content and activity, and incubated for 24 h reduced activity, P450 content, and amount of CYP1A1 and 1A2 proteins. The present study demonstrates that 1) the effect of RSTIAR and HSURVI depends upon the susceptibility of the hepatocyte, i.e., HCONT or primed HINFLA; 2) P450 down-regulation is preceded by a decrease in P450 activity; 3) the nature of the inflammatory reaction determines the repercussions on P450 activity and expression; and 4) CYP3A6 is more vulnerable than CYP1A1 and 1A2 to the down-regulation provoked by an inflammatory challenge.
Footnotes
-
This study was supported by a grant from the Canadian Institutes of Health Research (MOP-43925).
- Abbreviations used are::
- P450
- cytochrome P450
- IFN
- interferon
- CYP
- apoprotein of the cytochrome P450
- IL
- interleukin
- TNF-α
- tumor necrosis factor-α
- HSURVI
- serum from human with an upper respiratory viral infection
- TIAR
- turpentine-induced acute inflammatory reaction
- RSTIAR
- serum from rabbits with a turpentine-induced acute inflammatory reaction
- HINFLA
- hepatocytes from rabbit with a turpentine-induced acute inflammatory reaction
- HCONT
- hepatocytes from control rabbit
- 3 MX
- 3-methylxanthine
- 1 MU
- 1-methyluric acid
- 1,3DMU
- 1,3-dimethyluric acid
- RSCONT
- serum from control rabbits
- HSCONT serum from control volunteers
- URVI, upper respiratory viral infection
- NOS
- nitric-oxide synthase
- Received December 12, 2000.
- Accepted March 20, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|